Browsing: personalised medicine

In a trial led by NUS, artificial intelligence platform CURATE.AI personalised treatment for a rare blood cancer patient by dynamically adjusting their drug dosages based on real-time responses. This AI-guided approach improved the patient’s condition while reducing costs and side effects by delivering precisely dosed medications through an evolving personalised profile.

Significant Funding for Precision Oncology Singapore’s fight against cancer has received a significant boost with a $50 million grant awarded…

Explore the transformative role of personalised medicine in cancer treatment, blending human expertise with AI advancements.

Dr Steven Tucker answers audience questions live on our Doctor-On-Call webinar, on cancer screening & prevention, genetic testing and more!

Early diagnosis through cancer screening can offer a better chance of cure, and preventive care can reduce the risk of getting cancer in the first place.